Trials / Completed
CompletedNCT01553305
A Study of the Effect of Supervised Exercise Programme in Patients With Rheumatoid Arthritis
The Effect of 6-weeks Supervised Exercise Programme Followed by 6-weeks Unsupervised Exercise Programme Versus 12 Weeks Unsupervised Exercise Programme in Patients With Rheumatoid Arthritis.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effectiveness of a supervised high-intensity exercise programme followed by an unsupervised exercise programme to an unsupervised exercise programme in patients with Rheumatoid Arthritis.
Detailed description
Patients with Rheumatoid Arthritis are in general less fit and more at risk of comorbidities such as cardiovascular events compared with healthy age-matched controls. Studies indicates that patients with Rheumatoid Arthritis have a lower level of physical activity than the general population and a low proportion of patients with Rheumatoid Arthritis exercises. Regular exercise with moderate to high intensity level of intensity has proven to be effective in reducing the cardiovascular risk by improving cardiovascular fitness and to increase muscle strength. Therefore, it is of interest to investigate if supervised exercise programme makes a difference making patients with Rheumatoid Arthritis participate in exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Supervised high-intensity exercise programme | Six-weeks supervised high-intensity muscle strength training and physical fitness with training sessions twice a week followed by 6-weeks unsupervised high-intensity exercise programme. |
| OTHER | Exercise programme | Supervised exercise programme |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-03-14
- Last updated
- 2013-07-04
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01553305. Inclusion in this directory is not an endorsement.